Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content:
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content:
Board of Directors' decisions held on 07/11/2026 including the unaudited financial results of the period ended on 30/09/2026.
Decisions of the BoD Meeting (2,780 KB)
